Delivery Order SPE2DB20D7066-SPE2DB25FC3VZ
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIOVAN HCT 160-25 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $31,043.04 and a performance period through June 16, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,736.95, is for the delivery of DIOVAN HCT 160-12.5 MG TAB 90S, a cardiovascular medication. The contract has a completion date of November 1, 2023 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIOVAN HCT 160-12.5 MG TAB 90S medication. The award has a ceiling value of $12,009.39 and a completion date of August 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office Division, will provide the specified pharmaceutical product to support the...
- This is a $1,991.83 Firm Fixed Price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of DIOVAN HCT 320-12.5 MG TAB 90S, a prescription medication. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a Delivery Order (DO) contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract has a ceiling value of $4,590.29 and a period of performance through January 27, 2025. The contract is a Firm Fixed Price (FFP) arrangement and was not set aside for any specific business category....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,943.57 delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of June 16, 2025. It is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,212.36 and an ultimate completion date of June 16, 2025. The contract provides for the delivery of Diovan HCT 160-25 mg tablets in quantities of 90. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $31,914.40 and is for the delivery of Diovan HCT 160-25 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,872.47 Firm Fixed Price delivery order is for the provision of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of March 22, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $5,996.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIOVAN HCT 320-25 MG TABLET 90S, a cardiovascular medication, with a completion date of November 6, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3VZDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIOVAN HCT 160-12.5 MG TAB 90S, a prescription medication, with a firm fixed price ceiling value of $3,972.63 and a performance period through June 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 6/27/25 |